传染病。首批特效药物为丙型肝炎带来希望。 - Suppr

Suppr

超能文献

Infectious diseases. First specific drugs raise hopes for hepatitis C.

作者信息

Enserink Martin

出版信息

Science. 2011 Apr 8;332(6026):159-60. doi: 10.1126/science.332.6026.159.

DOI:10.1126/science.332.6026.159

PMID:21474720

Abstract

摘要

相似文献

Infectious diseases. First specific drugs raise hopes for hepatitis C.传染病。首批特效药物为丙型肝炎带来希望。

Science. 2011 Apr 8;332(6026):159-60. doi: 10.1126/science.332.6026.159.

[Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].[慢性丙型肝炎抗病毒治疗的未来。直接抗病毒药物]

Pharm Unserer Zeit. 2011 Jan;40(1):60-7. doi: 10.1002/pauz.201100401.

[A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].丙型肝炎治疗的新时代：“现在治疗可以个体化了”（医学博士德克·艾内克访谈）

MMW Fortschr Med. 2011 Jul 21;153(29-31):17.

[Therapy of hepatitis C: new inhibitors as hammers against HCV].[丙型肝炎的治疗：新型抑制剂作为对抗丙肝病毒的“锤子”]

MMW Fortschr Med. 2013 Jun 13;155 Suppl 1:10-1.

The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.第一波：丙型肝炎病毒NS3蛋白酶抑制剂特拉匹韦和波普瑞韦。

Antivir Ther. 2012;17(6 Pt B):1119-31. doi: 10.3851/IMP2424. Epub 2012 Oct 5.

[New times for the treatment of chronic hepatitis C].[慢性丙型肝炎治疗的新时代]

Ugeskr Laeger. 2012 Mar 19;174(12):795.

[Studies with boceprevir].[博赛泼维的研究]

MMW Fortschr Med. 2011 Jul 21;153(29-31):16.

Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.慢性丙型肝炎直接抗病毒治疗的经济学评估

Antivir Ther. 2012;17(6 Pt B):1189-99. doi: 10.3851/IMP2430. Epub 2012 Oct 5.

New hepatitis C regimen stimulates changes in therapy management.

Manag Care. 2011 Dec;20(12):41-2.

New developments in HCV therapy.HCV 治疗的新进展。

J Viral Hepat. 2012 Jan;19 Suppl 1:48-51. doi: 10.1111/j.1365-2893.2011.01526.x.

引用本文的文献

A dynamic model and some strategies on how to prevent and control hepatitis c in mainland China.中国大陆丙型肝炎的预防和控制的动力学模型及策略。

BMC Infect Dis. 2019 Aug 16;19(1):724. doi: 10.1186/s12879-019-4311-x.

Identification of three antiviral inhibitors against Japanese encephalitis virus from library of pharmacologically active compounds 1280.从1280种药理活性化合物库中鉴定出三种抗日本脑炎病毒的抗病毒抑制剂。

PLoS One. 2013 Nov 4;8(11):e78425. doi: 10.1371/journal.pone.0078425. eCollection 2013.

Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective.丙型肝炎病毒对新型特异性靶向抗病毒治疗的耐药性：公共卫生视角

World J Virol. 2013 Feb 12;2(1):6-15. doi: 10.5501/wjv.v2.i1.6.

Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation.荧光千里光碱衍生物抑制丙型肝炎病毒 NS3 催化的 RNA 解链、肽水解和病毒复制酶形成。

Antiviral Res. 2012 Nov;96(2):245-55. doi: 10.1016/j.antiviral.2012.08.006. Epub 2012 Aug 25.

Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches.丙型肝炎病毒 RNA 结构域与翻译抑制剂复合物的结构揭示了一种类似于核糖体开关的结合模式。

Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5223-8. doi: 10.1073/pnas.1118699109. Epub 2012 Mar 19.

Sequence analysis of the IL28A/IL28B inverted gene duplication that contains polymorphisms associated with treatment response in hepatitis C patients.对与丙型肝炎患者治疗反应相关的多态性相关的 IL28A/IL28B 倒置基因重复序列进行分析。

PLoS One. 2012;7(1):e29983. doi: 10.1371/journal.pone.0029983. Epub 2012 Jan 10.

PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus.PD 404,182 是一种杀病毒小分子，可破坏丙型肝炎病毒和人类免疫缺陷病毒。

Antimicrob Agents Chemother. 2012 Feb;56(2):672-81. doi: 10.1128/AAC.05722-11. Epub 2011 Nov 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验